indications for semaglutide vs GLP-1: Key Differences Explained Indications for oral semaglutide |

It was photos from a cruise trip that finally pushed Joelle Potter to the breaking point in her weight loss journey

Tirzepatide A dual-acting medication that targets both GLP-1 and GIP receptors, offering an advanced approach to weight control and blood sugar management

Severe gastrointestinal symptoms during semaglutide treatment, including persistent nausea, vomiting, or diarrhea, warrant medical consultation, particularly in anticoagulated patients

doi:10.1016/j.eclinm.2024.103029 25.Ayoub M, Chela H, Amin N, et al

But the weight loss process itself can trigger inflammatory responses, particularly in joints and connective tissue as the body adapts to carrying less weight